White Paper: Why Annex 1 Is Important to You
May 12, 2017
This white paper details the key reasons for the revision to EudraLex Volume 4, Annex 1: Manufacture of Sterile Medicinal Products. It outlines what you should be asking yourself regardless of the dosage form you are responsible for. It also includes a simple tool to assess the impact on your organization when there is a regulatory change.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Welcomes Mel Cash as Chief Commercial Officer
October 14, 2024Global public health and safety organisation announces new Commercial lead to drive growth and innovation.
Read the Story
NSF Spotlighted in “SDG Leaders” Series on CNBC.com
October 3, 2024The docuseries highlights businesses that are addressing core issues within the 17 United Nations (UN) Sustainable Development Goals (SDGs), offering a glimpse into what people can expect as these organisations strive to tackle existential challenges, embedding the sustainability goals at the heart of their work.
Read the Story
NSF Celebrates 80 Years of Improving Human and Planet Health
September 12, 2024NSF has been pioneering public and environmental health since 1944 by developing and implementing public and environmental health standards.
Read the Story
NSF To Host Pharma Compliance to Performance Conference
September 5, 2024NSF will host its 2nd pharmaceutical conference in London on November 14th, 2024.
Read the Story